Steven Cohen Immunocore Holdings PLC Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$25.46 - $37.72 $10.4 Million - $15.4 Million	-407,058 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$18.94 - $34.29 $7.47 Million - $13.5 Million	394,658 Added 3182.73%	407,058 $12.2 Million
Q4 2021 Feb 14, 2022	SELL	$27.58 - $40.0 $3.77 Million - $5.46 Million	-136,600 Reduced 91.68%	12,400 $425,000
Q3 2021 Nov 15, 2021	BUY	$27.98 - $40.0 $2.13 Million - $3.04 Million	76,100 Added 104.39%	149,000 $5.52 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $41.5 $2.35 Million - $3.03 Million	72,900 New	72,900 $2.85 Million

163

37.8M

540K

97.3K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.53B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.